The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): A randomised controlled trial

BMC Family Practice

Volumn 13, Issue , 2012, Pages

  Selvaraj, Francis Jude ^a   Mohamed, Mafauzy ^b   Omar, Khairani ^c   Nanthan, Sudha ^d   Kusiar, Zainab ^e   Subramaniam, Selvaraj Y ^f   Ali, Norsiah ^g   Karanakaran, Kamalakaran ^h   Ahmad, Fauziah ⁱ   Low, Wilson H H ^j  

^a Eli Lilly (M) Sdn Bhd   (Malaysia)

^b HOSPITAL UNIVERSITI SAINS MALAYSIA   (Malaysia)

^c DEPARTMENT OF PHARMACOLOGY   (Malaysia)

^d Polyclinic and Surgery Ayer Molek   (Malaysia)

^e Nilai Health Clinic   (Malaysia)

^f Awana Kijal Clinic   (Malaysia)

^g Tampin Health Clinic   (Malaysia)

^h Kapar Clinic   (Malaysia)

ⁱ Bagan Serai Health Clinic   (Malaysia)

^j Azmi Burhani Consulting   (Malaysia)

more..

Author keywords

Cardiovascular risk control; Disease management; Dyslipidaemia; Patient support

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MANAGEMENT; DYSLIPIDEMIA; FEMALE; HUMAN; MALAYSIA; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DISEASE MANAGEMENT; DYSLIPIDEMIAS; FEMALE; HUMANS; MALAYSIA; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; TRIGLYCERIDES;

MLCS; MLOWN;

EID: 84867216448     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-13-97     Document Type: Article

References (29)

1. World Health Organization, Preventing chronic diseases: a vital investment: WHO global report Geneva: WHO Press 2005
2. Chronic diseases in developing countries: Health and economic burdens. Nugent R, Ann N Y Acad Sci 2008 1136 70 79 10.1196/annals.1425.027 18579877
3. World Health Organization, Innovative care for chronic conditions: building blocks for action Geneva: WHO Press 2002
4. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Beaglehole R, Epping-Jordan J, Patel V, Chopra M, Ebrahim S, Kidd M, Lancet 2008 372 940 949 10.1016/S0140-6736(08)61404-X 18790317
5. Improving the quality of health care for chronic conditions. Epping-Jordan J, Pruitt S, Bengoa R, Wagner E, Qual Saf Health Care 2004 13 299 305 10.1136/qshc.2004.010744 15289634
6. Does disease management improve clinical and economic outomces in patients with chronic diseases? A systematic review. Ofman J, Badamgarav E, Henning J, Knight K, Gano A, Levan R, Gur-Arie S, Richards MS, Hasselblad V, Weingarten SR, Am J Med 2004 117 182 192 10.1016/j.amjmed.2004.03.018 15300966
7. Shekelle P, Maglione M, Chodosh J, Mojica W, Morton SC, Suttorp MJ, Roth EA, Rhodes S, McKinnon E, Wu S-Y, Rubenstein L, Lapin P, Chronic disease self-management for diabetes, osteoarthritis, post-myocardial infarction care and hypertension Santa Monica: RAND Corporation 2004
8. A meta-analysis of interventions to improve care for chronic illnesses. Tsai A, Morton S, Mangione C, Keeler E, Am J Mang Care 2005 11 478 488
9. Zwar N, Harris M, Griffiths R, Roland M, Dennis S, Powell Davies G, Hasan I, Systematic review of chronic disease management Sydney: Research Centre for Primary Health Care and Equity 2006
10. Yusoff AF, Mustafa AN, Kaur G, Omar MA, Vos T, Rao VPC, Begg S, Malaysian burden of disease and injury study 2005 Kuala Lumpur: Institute of Public Health, National Institutes of Health Malaysia 2005
11. Malaysia Ministry of Health, National Health Morbidity Survey III Kuala Lumpur: Institute of Public Health Malaysia 2008
12. Managing chronic diseases in the Malaysian primary health care-a need for change. Ramli A, Taher S, Malaysian Family Physician 2008 3 1 7 13
13. Panel discussion: chronic disease management in private general practice: what is the future? Low W, Malays Fam Physician 2010 5 1 57 58
14. Surveillance and treatment of dyslipidaemia in the post-infarct patient: can a nurse-led management approach make a difference? Lapointe F, Lepage S, Larrivee L, Maheux P, Can J Cardiol 2006 22 9 761 767 10.1016/S0828-282X(06) 70292-6 16835670
15. Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial. New JP, Mason JM, Freemantle N, Teasdale Sue, Wong LM, Bruce NJ, Burns JA, Gibson JM, Diabetes Care 2003 26 2250 2255 10.2337/diacare.26.8.2250 12882844
16. Coaching patients on achieving cardiovascular health (COACH): a multicenter randomized trial in patients with coronary heart disease. Vale M, Jelinek M, Best J, Dart A, Griggs L, Hare D, Ho BP, Newman RW, McNeil JJ, Arch Intern Med 2003 163 2775 2783 10.1001/archinte.163.22.2775 14662633
17. Community Outreach and Cardiovascular Health (COACH) trial: a randomized, controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers. Allen JK, Dennison-Himmerlfarb CR, Szanton SL, Bone L, Hill MN, Levine DM, Barlow A, Lewis-Boyer LP, Donnelly-Strozzo M, Curtis C, Anderson K, Circ Cardiovasc Qual Outcomes 2011 4 595 602 10.1161/CIRCOUTCOMES.111.961573 21953407
18. National Institute of Health (NIH), Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final Report Bethesda: NIH Publication 2002
19. Malaysia primary care providers characteristics and workload: the national primary care survey. Zailinawati AH, Tong SF, Nordin S, Lee VKM, Mimi O, Khoo EM, Chen WS, Teng CL, Malays Fam Physician 2009 4 supp 2 48 49
20. A randomized controlled trial of a public health nurse directed treatment program for rural patients with high blood cholesterol. Ammerman A, Keyserling T, Atwood J, Hosking J, Zayed H, Krasny C, Prev Med 2003 36 3 340 351 10.1016/S0091-7435(02)00042-7 12634025
21. A nurse-based pilot program to reduce cardiovascular risk factors in a primary care setting. McPherson CP, Swenson KK, Pine DA, Leimer L, Am J Mang Care 2002 8 543 555
22. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Allen JK, Blumenthal RS, Margolis S, Young DR, Miller ER III, Kelly K, Am Heart J 2002 144 678 686 12360165
23. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management (SCRIP). Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, Cave A, Chang WC, Dzavik V, Farris KB, Galvin D, Semchuk W, Taylor JG, Arch Intern Med 2002 162 1149 1155 10.1001/archinte.162.10.1149 12020186
24. A pharmacy-based approach to cholesterol management. DiTusa L, Luzier AB, Brady G, Reinhardt M, Snyder BD, Am J Manag Care 2001 7 973 979 11669361
25. High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease. Kapur NK, Ashen D, Blumenthal RS, Vasc Health Risk Manag 2008 4 1 39 57 10.2147/vhrm.2008.04.01.39 18629371
26. Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER database. Barter PJ, Brandrup-Wognsen G, Palmer MK, Nicholls SJ, J Lipid Res 2010 51 1546 1553 10.1194/jlr.P002816 19965573
27. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Berglund L, Oliver EH, Fontanez N, Holleran S, Matthews K, Roheim PS, Ginsberg HM, Ramakrishnan R, Lefevre M, Am J Clin Nutr 1999 70 992 1000 10584043
28. Differential response to low-fat diet between low and normal HDL-cholesterol subjects. Asztalos B, Lefevre M, Wong L, Foster TA, Tulley R, Windhauser M, Zhang WW, Roheim PS, J Lipid Res 2000 41 321 328 10706579
29. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL Apolipoprotein transport rates. Brinton EA, Eisenberg S, Breslow JL, J Clin Invest 1990 85 144 151 10.1172/JCI114405 2104877